Ex Vivo Major Histocompatibility Complex I Knockdown Prolongs Rejection-free Allograft Survival

BACKGROUND: Widespread application of vascularized composite allotransplantation (VCA) is currently limited by the required lifelong systemic immunosuppression and its associated morbidity and mortality. This study evaluated the efficacy of ex vivo (after procurement but before transplantation) engi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jessica B., Rifkin, William J., Soares, Marc A., Duckworth, April, Rao, Nakul, Low, Yee Cheng, Massie, Jonathan P., Rabbani, Piul S., Saadeh, Pierre B., Ceradini, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Experimental
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157929/
https://www.ncbi.nlm.nih.gov/pubmed/30276052
http://dx.doi.org/10.1097/GOX.0000000000001825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157929/
https://www.ncbi.nlm.nih.gov/pubmed/30276052
http://dx.doi.org/10.1097/GOX.0000000000001825

Ejemplares similares